- IN₹90.12bn
- IN₹94.47bn
- IN₹34.20bn
Brief: SeQuent Scientific Gets Suitability Certificate For Its Generic API Diclazuril In The EU
Brief: Sequent Scientific Launches Citramox Suspension Injection In 10 European Countries
Brief: SeQuent Scientific Launches Halofusol Oral Solution For Calves In 19 European Countries
Brief: India's Sequent Scientific Sept-Quarter Consol PAT Falls
Brief: SeQuent Scientific Acquires Incremental Stake Of 15% In Fendigo BV, A Unit Of Co
India's Carlyle-backed Sequent Scientific up on deal to buy Provet stake
Brief: Sequent Scientific Taps Kamal K Sharma As Chairman
Brief: India's SeQuent Scientific March-Quarter Consol PAT Falls
SeQuent Scientific rises nearly 5% on Carlyle deal
Brief: Sequent Scientific -Some Promoters Propose To Sell Entire Shareholding In Co To CA Harbor Investments
Brief: Sequent Scientific Says Carlyle Group To Buy Stake In Co
Brief: CA Harbor Investments Offers To Buy Stake In India's Sequent Scientific -Offer Document
Media: Carlyle to buy up to 75% stake in India's SeQuent Scientific - Economic Times
Capacity Expansion Project At Germany Plant Put On Hold
Brief: India's Sequent Scientific Sept Qtr Consol PAT Rises
Brief: SeQuent Scientific Gets EIR From US FDA For Bengaluru Analytical Laboratory
Brief: India's Sequent Scientific March-Qtr Consol Profit Falls
Brief: Sequent Scientific Approves Appointment Of Rakesh Bhatnagar As CFO
Brief: India's Sequent Scientific Posts Dec-Qtr Profit